A study to test how well different doses of BI 4060107 are tolerated by people with advanced cancer (solid tumours)

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: d41dd27a569a2a827db396614862029af47b6054
First added on: Nov 01, 2026